![]() |
|
|
The Journal of Nutrition Vol. 128 No. 2 February 1998,
pp. 209-213
Department of Public Health, Gifu University School of Medicine, Gifu 500, Japan
| |
ABSTRACT |
|---|
|
|
|---|
The relationship between soy product intake and serum total cholesterol concentration was examined in 1242 men and 3596 women who participated in an annual health check-up program in Takayama City, Japan, provided by the municipality in 1992. The intake of soy products and various foods and nutrients was assessed by a semiquantitative food-frequency questionnaire. Blood samples were collected from fasting subjects to measure the serum total cholesterol concentration. A significant trend (P for trend = 0.0001) was observed for decreasing total cholesterol concentration with an increasing intake of soy products in men after controlling for age, smoking status and intake of total energy, total protein and total fat. This negative trend (P for trend = 0.0001) was also noted in women after controlling for age, menopausal status, body mass index and intake of total energy and vitamin C. An additional adjustment for physical activity, coffee and tea consumption, and intake of cholesterol, carbohydrates, fiber and vitamin E did not change the results. These data suggest a role for soy products in human cholesterol homeostasis.
KEY WORDS: cholesterol · soy products · diet · Japan · humans
Animal studies have demonstrated that the concentration of cholesterol in blood is lowered by consumption of soy protein rather than animal protein (Carroll and Kurowska 1995 To our knowledge, no other cross-sectional studies on the relationship between soy intake and cholesterol concentration currently exist. The relative homogeneity of nutrient intake levels within a population and the errors associated with measurements of diet would make it difficult to detect an association between soy intake and cholesterol level. Soy products such as tofu and miso are traditional Japanese foods and are still popular among Japanese. These characteristics might help us obtain a relatively large variation in intake of these foods among subjects and high reliability in measuring the intake.
Although the previous dietary intervention studies were designed to set up relatively large differences in soy protein intake among the groups compared, the duration of interventions was generally short. The cross-sectional study has limitations in that no causal inference is drawn; however, such a study reflects the association of cholesterol with the usual diet of the subjects over longer periods. Using a cross-sectional study, we examined the relationship between soy products and serum cholesterol concentration in a community in Japan.
The Takayama Study is a prospective cohort study investigating the role of diet and lifestyle on the subsequent development of cancer (Shimizu 1996 The validity of this dietary questionnaire has been tested by the use of other dietary assessment methods, one 3-d diet record, four 24-h recalls over 1 y and 12 daily diet records at ~1-mo intervals over 1 y. The Spearman correlation coefficients comparing intake of soy products estimated from the questionnaire with that from 12 daily diet records were as follows: 0.71 and 0.72 for the total amount (grams) of soy products, 0.57 and 0.70 for tofu, 0.83 and 0.76 for miso, 0.66 and 0.79 for natto (fermented soybeans), 0.42 and 0.36 for soybeans and 0.38 and 0.52 for the other soy products in men and women, respectively. The correlation coefficients for intake of fat (total fat, and saturated, polyunsaturated and monounsaturated fat), protein (animal and vegetable protein), cholesterol, carbohydrate, crude fiber, and vitamins C and E from the whole meals between the two methods varied from 0.21 for fat in men to 0.67 for crude fiber in women (the average correlation coefficient for these nutrients was 0.43 and 0.50 for men and women, respectively). Although the correlation for fat intake was low in men (0.21) between the questionnaire and the 12 daily diet records, the correlations comparing the questionnaire with one 3-d diet record and four 24-h recalls were relatively high (0.38 and 0.37, respectively). The average intake of soy products by men and women is shown in Table 1. Soy product intake may be underestimated by our questionnaire. In the validity test, the mean intake of total soy products estimated from the 12 daily diet records over 1 y was ~30% higher than that estimated from the questionnaire.
The finding in this study of decreasing serum total cholesterol concentration with increasing soy product intake after multivariate adjustments supports the results of some previous clinical trials showing the cholesterol-lowering effect of soy protein (Carroll et al. 1978
![]()
INTRODUCTION
Abstract
Introduction
Methods
Results
Discussion
References
, Meeker and Kesten 1941
). The effect of dietary soy protein on serum cholesterol concentration has been examined in humans in many clinical trials, but the results have not been consistent. Although significantly decreased plasma or serum cholesterol concentration in some hypercholesterolemic subjects as a result of soy-protein diets was reported in some studies (Bakhit et al. 1994
, Sirtori et al. 1977
, Verrillo et al. 1985
), most studies of normocholesterolemic subjects have shown little difference in effects on plasma or serum cholesterol concentration between soy protein and control diets (Giovannetti et al. 1986
, Grundy and Abrams 1983
, Meinertz et al. 1988
, Mendis and Kumarasunderam 1990
, Raaij et al. 1981
and 1982, Sacks et al. 1983
). In 1993, the American Heart Association concluded that the positive nature of the effects of soy protein on cholesterol concentration in humans was not so convincing (Chait et al. 1993
). However, Anderson et al. (1995)
recently performed a meta-analysis of earlier clinical trials and reported that the replacement of animal protein in the diet with soy protein was associated with a significant decrease in serum cholesterol concentration.
![]()
MATERIALS AND METHODS
Abstract
Introduction
Methods
Results
Discussion
References
). About 31,000 persons, 92% of all residents
35 y of age in Takayama City, Japan, participated in the Takayama Study in 1992. Among the participants in the study, 1242 men and 3596 women, who attended the annual health check-up program provided by Takayama Municipality between April and October 1992, were selected as the subjects of this study. We refer to those who were cohort members of the Takayama Study and who did not attend this health check-up program as nonparticipants.
) using an Auto Analyzer (Hitachi, Tokyo, Japan). The reagent used was L-type Wako Cholesterol purchased from Wako Junyaku, Osaka, Japan. The weight and height of each subject were measured and the body mass index (BMI, kg/m2) was calculated.
.
). Each activity level was assigned an intensity score according to the relative metabolic rate method (Numajiri 1979
). The hours spent at each level of activity, weighted by these intensity scores, were totaled to quantify the physical activity level of each individual. The validity of this method was tested (Department of Public Health, Gifu University School of Medicine). The Spearman correlation coefficients comparing energy expenditure estimated from the questionnaire with that measured by the well-established Calorie Counter method (Yanagibori et al. 1991
) were 0.69 for both men and women (Suzuki et al., unpublished data).
. The variables for intake of soy products and soy protein were categorized by quartile after adjusting for total energy. The relationships between serum total cholesterol concentration and the intake of soy products or soy protein were assessed primarily by a test for trends using multiple regression techniques (Kirk 1982
). Standard regression techniques (Kirk 1982
) were also used for analysis of the relationships of selected dietary and anthropometric variables to the intake of soy products or soy protein and to test for adjusted mean values. Correlation analyses (Zar 1984
) were used to examine the associations of these variables to serum total cholesterol concentration. The potential confounding factors for the associations of serum total cholesterol concentration with the intake of soy products or soy protein were included in the model simultaneously. All of the statistical analyses were performed using SAS programs (SAS/STAT Version 6.11, SAS Institute, Cary, NC).
![]()
RESULTS
Abstract
Introduction
Methods
Results
Discussion
References
View this table:
Table 1.
Characteristics of the subjects and intake of soy products by men and women1
View this table:
Table 2.
Pearson correlations of various nutrient intakes and other factors with serum total cholesterol concentration and the means of the factors according to quartile of soy product intake among Japanese men and women1
View this table:
Table 3.
Serum total cholesterol concentration according to quartile of intake of soy products and soy protein among
Japanese men and women1
![]()
DISCUSSION
Abstract
Introduction
Methods
Results
Discussion
References
, Chait et al. 1993
). It is of interest that we were able to confirm this relationship in a cross-sectional study. From the results of meta-analysis, Anderson et al. (1995)
suggested that 25 g soy protein/d would be associated with a decrease in serum total cholesterol concentration of 0.45 mmol/L. Our dietary questionnaire was designed to measure an individual's relative rather than absolute nutrient intakes. Therefore we cannot directly compare the estimate of soy protein intake in this study with the amount of soy protein fed to the subjects in clinical trials. It is also possible that the relationship between total cholesterol concentration and soy protein intake observed in dietary interventions of short duration might differ from that observed in cross-sectional studies. However, the association observed between soy protein intake and serum total cholesterol concentration, i.e., a 0.31 mmol/L decrease in serum total cholesterol with a 9.6 g increase in soy protein intake between the 1st and the 4th quartiles in men and a 0.23 mmol/L decrease in serum total cholesterol with a 7.9 g increase in soy protein intake between the 1st and the 4th quartiles in women, was not greatly different from that suggested by Anderson et al (1995). A decrease of 0.23 mmol/L in serum total cholesterol was reported by Carroll et al. (1978)
among normocholesterolemic women after soy protein was substituted for animal protein in diets for 37 d. No effects of soy protein diets were observed in other studies of normocholesterolemic subjects (Carroll 1991
).
| |
FOOTNOTES |
|---|
Manuscript received 22 May 1997. Initial reviews completed 1 July 1997. Revision accepted 31 October 1997.
| |
LITERATURE CITED |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
K. D. R. Setchell, X. Zhao, S. E. Shoaf, and K. Ragland The Pharmacokinetics of S-(-)Equol Administered as SE5-OH Tablets to Healthy Postmenopausal Women J. Nutr., November 1, 2009; 139(11): 2037 - 2043. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Setchell, X. Zhao, P. Jha, J. E Heubi, and N. M Brown The pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers Am. J. Clinical Nutrition, October 1, 2009; 90(4): 1029 - 1037. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Pipe, C. P. Gobert, S. E. Capes, G. A. Darlington, J. W. Lampe, and A. M. Duncan Soy Protein Reduces Serum LDL Cholesterol and the LDL Cholesterol:HDL Cholesterol and Apolipoprotein B:Apolipoprotein A-I Ratios in Adults with Type 2 Diabetes J. Nutr., September 1, 2009; 139(9): 1700 - 1706. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pan, O. H. Franco, J. Ye, W. Demark-Wahnefried, X. Ye, Z. Yu, H. Li, and X. Lin Soy Protein Intake Has Sex-Specific Effects on the Risk of Metabolic Syndrome in Middle-Aged and Elderly Chinese J. Nutr., December 1, 2008; 138(12): 2413 - 2421. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-C. Yang, S.-M. Liu, H.-Y. Yang, Y.-H. Lin, and J.-R. Chen Soybean Protein Hydrolysate Improves Plasma and Liver Lipid Profiles in Rats Fed High-Cholesterol Diet J. Am. Coll. Nutr., October 1, 2007; 26(5): 416 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Clerici, K. D. R. Setchell, P. M. Battezzati, M. Pirro, V. Giuliano, S. Asciutti, D. Castellani, E. Nardi, G. Sabatino, S. Orlandi, et al. Pasta Naturally Enriched with Isoflavone Aglycons from Soy Germ Reduces Serum Lipids and Improves Markers of Cardiovascular Risk J. Nutr., October 1, 2007; 137(10): 2270 - 2278. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R Matthan, S. M Jalbert, L. M Ausman, J. T Kuvin, R. H Karas, and A. H Lichtenstein Effect of soy protein from differently processed products on cardiovascular disease risk factors and vascular endothelial function in hypercholesterolemic subjects Am. J. Clinical Nutrition, April 1, 2007; 85(4): 960 - 966. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Manjanatha, S. Shelton, M. E. Bishop, L. E. Lyn-Cook, and A. Aidoo Dietary effects of soy isoflavones daidzein and genistein on 7,12-dimethylbenz[a]anthracene-induced mammary mutagenesis and carcinogenesis in ovariectomized Big Blue(R) transgenic rats. Carcinogenesis, December 1, 2006; 27(12): 2555 - 2564. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dewell, P. L. W. Hollenbeck, and C. B. Hollenbeck A Critical Evaluation of the Role of Soy Protein and Isoflavone Supplementation in the Control of Plasma Cholesterol Concentrations J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 772 - 780. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yang, Z. T. Zhou, and J. P. Ge Effect of genistein on DMBA-induced oral carcinogenesis in hamster Carcinogenesis, March 1, 2006; 27(3): 578 - 583. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L McVeigh, B. L Dillingham, J. W Lampe, and A. M Duncan Effect of soy protein varying in isoflavone content on serum lipids in healthy young men Am. J. Clinical Nutrition, February 1, 2006; 83(2): 244 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Melby, M. Lock, and P. Kaufert Culture and symptom reporting at menopause Hum. Reprod. Update, September 1, 2005; 11(5): 495 - 512. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Messina and J. W Erdman Jr Need to establish threshold soy protein intake for cholesterol reduction Am. J. Clinical Nutrition, April 1, 2005; 81(4): 942 - 943. [Full Text] [PDF] |
||||
![]() |
J. A. Nettleton, K. A. Greany, W. Thomas, K. E. Wangen, H. Adlercreutz, and M. S. Kurzer The Effect of Soy Consumption on the Urinary 2:16-Hydroxyestrone Ratio in Postmenopausal Women Depends on Equol Production Status but Is Not Influenced by Probiotic Consumption J. Nutr., March 1, 2005; 135(3): 603 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. T. van der Schouw, L. Sampson, W. C. Willett, and E. B. Rimm The Usual Intake of Lignans but Not That of Isoflavones May Be Related to Cardiovascular Risk Factors in U.S. Men J. Nutr., February 1, 2005; 135(2): 260 - 266. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vega-Lopez, K.-J. Yeum, J. L Lecker, L. M Ausman, E. J Johnson, S. Devaraj, I. Jialal, and A. H Lichtenstein Plasma antioxidant capacity in response to diets high in soy or animal protein with or without isoflavones Am. J. Clinical Nutrition, January 1, 2005; 81(1): 43 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S Rosell, P. N Appleby, E. A Spencer, and T. J Key Soy intake and blood cholesterol concentrations: a cross-sectional study of 1033 pre- and postmenopausal women in the Oxford arm of the European Prospective Investigation into Cancer and Nutrition Am. J. Clinical Nutrition, November 1, 2004; 80(5): 1391 - 1396. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Nagata, N. Takatsuka, N. Shimizu, and H. Shimizu Sodium Intake and Risk of Death From Stroke in Japanese Men and Women Stroke, July 1, 2004; 35(7): 1543 - 1547. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Erdman Jr., T. M. Badger, J. W. Lampe, K. D.R. Setchell, and M. Messina Not All Soy Products Are Created Equal: Caution Needed in Interpretation of Research Results J. Nutr., May 1, 2004; 134(5): 1229S - 1233S. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Takimoto, K. Glover, X. Huang, S. A. Hayes, L. Gallot, M. Quinn, B. D. Jovanovic, A. Shapiro, L. Hernandez, A. Goetz, et al. Phase I Pharmacokinetic and Pharmacodynamic Analysis of Unconjugated Soy Isoflavones Administered to Individuals with Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 2003; 12(11): 1213 - 1221. [Abstract] [Full Text] |
||||
![]() |
K. D. Setchell and E. Lydeking-Olsen Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies Am. J. Clinical Nutrition, September 1, 2003; 78(3): 593S - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. R. Setchell, N. M. Brown, P. B. Desai, L. Zimmer-Nechimias, B. Wolfe, A. S. Jakate, V. Creutzinger, and J. E. Heubi Bioavailability, Disposition, and Dose-Response Effects of Soy Isoflavones When Consumed by Healthy Women at Physiologically Typical Dietary Intakes J. Nutr., April 1, 2003; 133(4): 1027 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Setchell, M. S Faughnan, T. Avades, L. Zimmer-Nechemias, N. M Brown, B. E Wolfe, W. T Brashear, P. Desai, M. F Oldfield, N. P Botting, et al. Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women Am. J. Clinical Nutrition, February 1, 2003; 77(2): 411 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. R. Setchell, N. M. Brown, and E. Lydeking-Olsen The Clinical Importance of the Metabolite Equol--A Clue to the Effectiveness of Soy and Its Isoflavones J. Nutr., December 1, 2002; 132(12): 3577 - 3584. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Warren The Effects of Phytoestrogen Supplementation in Postmenopausal Women Reproductive Sciences, July 1, 2002; 9(4): 184 - 185. [PDF] |
||||
![]() |
M. Messina, C. Gardner, and S. Barnes Gaining Insight into the Health Effects of Soy but a Long Way Still to Go: Commentary on the Fourth International Symposium on the Role of Soy in Preventing and Treating Chronic Disease J. Nutr., March 1, 2002; 132(3): 547S - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Messina and C. L. Loprinzi Soy for Breast Cancer Survivors: A Critical Review of the Literature J. Nutr., November 1, 2001; 131(11): 3095S - 3108. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. R. Setchell Soy Isoflavones--Benefits and Risks from Nature's Selective Estrogen Receptor Modulators (SERMs) J. Am. Coll. Nutr., October 1, 2001; 20(90005): 354S - 362. [Abstract] [Full Text] |
||||
![]() |
M. G. Glazier and M. A. Bowman A Review of the Evidence for the Use of Phytoestrogens as a Replacement for Traditional Estrogen Replacement Therapy Arch Intern Med, May 14, 2001; 161(9): 1161 - 1172. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Goodman-Gruen and D. Kritz-Silverstein Usual Dietary Isoflavone Intake Is Associated with Cardiovascular Disease Risk Factors in Postmenopausal Women J. Nutr., April 1, 2001; 131(4): 1202 - 1206. [Abstract] [Full Text] |
||||
![]() |
K. D. R. Setchell, N. M. Brown, P. Desai, L. Zimmer-Nechemias, B. E. Wolfe, W. T. Brashear, A. S. Kirschner, A. Cassidy, and J. E. Heubi Bioavailability of Pure Isoflavones in Healthy Humans and Analysis of Commercial Soy Isoflavone Supplements J. Nutr., April 1, 2001; 131(4): 1362S - 1375. [Abstract] [Full Text] |
||||
![]() |
K. E Wangen, A. M Duncan, X. Xu, and M. S Kurzer Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women Am. J. Clinical Nutrition, February 1, 2001; 73(2): 225 - 231. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Erdman Jr Soy Protein and Cardiovascular Disease : A Statement for Healthcare Professionals From the Nutrition Committee of the AHA Circulation, November 14, 2000; 102(20): 2555 - 2559. [Full Text] [PDF] |
||||
![]() |
S. C. Ho, J. L. F. Woo, S. S. F. Leung, A. L. K. Sham, T. H. Lam, and E. D. Janus Intake of Soy Products Is Associated with Better Plasma Lipid Profiles in the Hong Kong Chinese Population J. Nutr., October 1, 2000; 130(10): 2590 - 2593. [Abstract] [Full Text] |
||||
![]() |
L.-J. W. Lu, K. E. Anderson, J. J. Grady, F. Kohen, and M. Nagamani Decreased Ovarian Hormones during a Soya Diet: Implications for Breast Cancer Prevention Cancer Res., August 1, 2000; 60(15): 4112 - 4121. [Abstract] [Full Text] |
||||
![]() |
B. E Merz-Demlow, A. M Duncan, K. E Wangen, X. Xu, T. P Carr, W. R Phipps, and M. S Kurzer Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women Am. J. Clinical Nutrition, June 1, 2000; 71(6): 1462 - 1469. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Wells, R. P. Jechorek, and S. L. Erlandsen Effect of Oral Genistein and Isoflavone-Free Diet on Cecal Flora and Bacterial Translocation in Antibiotic-Treated Mice JPEN J Parenter Enteral Nutr, March 1, 2000; 24(2): 56 - 60. [Abstract] [PDF] |
||||
![]() |
M. L. Fernandez, T. A. Wilson, K. Conde, M. Vergara-Jimenez, and R. J. Nicolosi Hamsters and Guinea Pigs Differ in Their Plasma Lipoprotein Cholesterol Distribution when Fed Diets Varying in Animal Protein, Soluble Fiber, or Cholesterol Content J. Nutr., July 1, 1999; 129(7): 1323 - 1332. [Abstract] [Full Text] |
||||
![]() |
C. L. Wells, R. P. Jechorek, K. M. Kinneberg, S. M. Debol, and S. L. Erlandsen The Isoflavone Genistein Inhibits Internalization of Enteric Bacteria by Cultured Caco-2 and HT-29 Enterocytes J. Nutr., March 1, 1999; 129(3): 634 - 640. [Abstract] [Full Text] |
||||
![]() |
K. D. R. Setchell and A. Cassidy Dietary Isoflavones: Biological Effects and Relevance to Human Health J. Nutr., March 1, 1999; 129(3): 758 - 758. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||